Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.

Incubation device features leap-frog power management and insulation technology that guarantees operation in low-resource settings with unreliable electricity.

GHT team to focus on inventing technology to improve the health of those who need it most.

IV's cervical cancer study was featured in Scientific American this month ahead of its publication in the magazine's April issue.

New, high-impact detection kit will prove useful for both P. falciparum and P. vivax species.